Chondroprotective effect of alendronate in a rabbit model of osteoarthritis

Journal of Orthopaedic Research

Volumn 29, Issue 10, 2011, Pages 1572-1577

  Shirai, Takaaki ^a   Kobayashi, Masahiko ^a   Nishitani, Kohei ^a   Satake, Tsuyoshi ^a   Kuroki, Hiroshi ^a   Nakagawa, Yasuaki ^b   Nakamura, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

alendronate; cartilage; knee; osteoarthritis; subchondral bone

Indexed keywords

ALENDRONIC ACID; COLLAGEN TYPE 10; COLLAGENASE 3; INTERLEUKIN 1BETA; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E SYNTHASE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; CARTILAGE DEGENERATION; CHONDROPROTECTION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CARTILAGE, ARTICULAR; DRUG EVALUATION, PRECLINICAL; FEMALE; IMMUNOHISTOCHEMISTRY; KNEE JOINT; OSTEOARTHRITIS, KNEE; RABBITS;

EID: 80051541993     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21394     Document Type: Article

References (28)

1. Burr DB,. 2004. Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 12 (Suppl A): S20-S30. (Pubitemid 38950273)
2. Oettmeier R, Abendroth K,. 1989. Osteoarthritis and bone: osteologic types of osteoarthritis of the hip. Skeletal Radiol 18: 165-174. (Pubitemid 19153608)
3. Felson DT, Neogi T,. 2004. Osteoarthritis: is it a disease of cartilage or of bone? [editorial]. Arthritis Rheum 50: 341-344. (Pubitemid 38198815)
4. Beuf O, Ghosh S, Newitt DC, et al. 2002. Magnetic resonance imaging of normal and osteoarthritic trabecular bone structure in the human knee. Arthritis Rheum 46: 385-393. (Pubitemid 34136576)
5. Kamibayashi L, Wyss UP, Cooke TD, et al. 1995. Trabecular microstructure in the medial condyle of the proximal tibia of patients with knee osteoarthritis. Bone 17: 27-35.
6. Dedrick DK, Goldstein SA, Brandt KD, et al. 1993. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months. Arthritis Rheum 36: 1460-1467. (Pubitemid 23304217)
7. Saag KG, Emkey R, Schnitzer TJ, et al. 1998. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339: 292-299. (Pubitemid 28366417)
8. Hayami T, Pickarski M, Wesolowski GA, et al. 2004. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50: 1193-1206. (Pubitemid 38480830)
9. Ding M, Danielsen CC, Hvid I,. 2008. The effects of bone remodeling inhibition by alendronate on three-dimensional microartitecture of subchondral bone tissue in guinea pig primary osteoarthritis. Calcif Tissue Int 82: 77-86.
10. Myers SL, Brandt KD, Burr DB, et al. 1999. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis. J Rheumatol 26: 2645-2653.
11. Nishitani K, Shirai T, Kobayashi M, et al. 2009. Positive effect of Alendronate on subchondral bone healing and subsequent cartilage repair in a rabbit osteochondral defect model. Am J Sports Med 37: 139S-147S.
12. Farrow LD, Gillespie RJ, Victoroff BN, et al. 2008. Radiographic location of the lateral intercondylar ridge: its relationship to Blumensaat's line. Am J Sports Med 36: 2002-2006.
13. Jones MD, Tran CW, Li G, et al. 2010. In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and anti-inflammatory drugs as preventive treatments of osteoarthritis in the rat. Arthritis Rheum 62: 2726-2735.
14. Mankin HJ, Dorfman H, Lippiello L, et al. 1971. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips: II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg 53A: 523-537.
15. van der Sluijs JA, Geesink RG, van der Linden AJ, et al. 1992. The reliability of the Mankin score for osteoarthritis. J Orthop Res 10: 58-61.
16. Goldring MB,. 2000. The role of the chondrocyte in osteoarthritis [review]. Arthritis Rheum 43: 1916-1926.
17. Kobayashi M, Squires GR, Mousa A, et al. 2005. Role of interleukin-1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52: 128-135. (Pubitemid 40129241)
18. Boos N, Nerlich AG, Wiest I, et al. 1999. Immunohistochemical analysis of type X-collagen expression in osteoarthritis of the hip joint. J Orthop Res 17: 495-502. (Pubitemid 29383608)
19. von der Mark K, Kirsch T, Nerlich AG, et al. 1992. Type X collagen synthesis in human osteoarthritic cartilage: indication of chondrocyte hypertrophy. Arthritis Rheum 35: 806-811.
20. Yasuda H, Shima N, Nakagawa N, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastgenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-3602.
21. Komuro H, Olee T, Kuhn K, et al. 2001. The osteoprotegerin/receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand system in cartilage. Arthritis Rheum 44: 2768-2776. (Pubitemid 34016196)
22. van Lent PL, Grevers L, Lubberts E, et al. 2006. Fcγ receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. Arthritis Rheum 54: 3868-3877. (Pubitemid 44955889)
23. Pufe T, Petersen W, Tillmann B, et al. 2001. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44: 1082-1088. (Pubitemid 32433613)
24. Hashimoto S, Creighton-Achermann L, Takahashi K, et al. 2002. Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 10: 180-187. (Pubitemid 34189567)
25. Fransès RE, McWilliams DF, Mapp PI, et al. 2010. Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarthritis Cartilage 18: 563-571.
26. Gosset M, Berenbaum F, Levy A, et al. 2006. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene. Arthritis Res Ther 8: R135.
27. Seedor JG, Quartuccio HA, Thompson DD,. 1991. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 6: 339-346.
28. Van Offel JF, Dombrecht EJ, Bridts CH, et al. 2005. Influence of bisphosphonates on the production of pro-inflammatory cytokines by activated human articular chondrocytes. Cytokine 31: 298-304. (Pubitemid 41097366)